Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

On May 22 nd, the Departments of Health and Human Services (HHS), Treasury and Labor announced a joint effort to advance ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

Following through on President Donald Trump’s “most favored nation” policy, the HHS is about to drop a drug pricing hammer on ...

The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...

We can move toward free market reforms in drug pricing. We must overturn the current perverse incentives that favor the ...

A new government-issued report reflects some of the most controversial views on vaccines, the nation’s food supply, ...

President Donald Trump recently signed an executive order aimed at lowering prescription drug prices. However, experts told KFF Health News the policy’s rollout reveals a slow, conditional path that ...

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump ...

Following President Donald Trump's most favored nation executive order, HHS and CMS have released the target price for ...

President Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he ...